Kevin Robert Lind

Insider Reports History

Location
San Diego, CA
Signature
/s/ Christopher Sullivan, by Power of Attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kevin Robert Lind:

Company Role Class Num Shares Value Price $ Report Date Ownership
Avalo Therapeutics, Inc. Director Stock Option (Right to Buy) 848 $12,499 $14.74 31 Dec 2025 Direct
Longboard Pharmaceuticals, Inc. President and CEO, Director Common Stock 0 $0 $60.00 02 Dec 2024 Direct
Longboard Pharmaceuticals, Inc. President and CEO, Director Stock Option (Right to Buy) 255,377 13 Nov 2024 Direct
Longboard Pharmaceuticals, Inc. President and CEO, Director Retention Restricted Stock Units 22,000 25 Oct 2024 Direct
Longboard Pharmaceuticals, Inc. President and CEO, Director Employee Stock Option (right to buy) 0 02 Dec 2024 Direct
Longboard Pharmaceuticals, Inc. President and CEO, Director Restricted Stock Unit 0 02 Dec 2024 Direct

Insider Reports Filed by Kevin Robert Lind